Results 251 to 260 of about 1,694,367 (292)

Pharmacological inhibitors of cyclin-dependent kinases

Trends in Pharmacological Sciences, 2002
Paul Greengard, Laurent Meijer, Marie Knockaert   +2 more
exaly  

KINASE INHIBITORS

2014
ALCARAZ LILIAN, HURLEY CHRISTOPHER, CRIDLAND ANDREW PETER, JENNINGS ANDREW STEPHEN ROBERT   +3 more
openaire   +8 more sources

Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview

Medicinal Research Reviews, 2017
Peter M. Fischer
exaly  

Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymes

FEBS Letters, 1996
Michael Gschwendt, W Kittstein, F J Johannes   +2 more
exaly  

Kinase inhibitors

2007
DAS SANJIB, BROWN JASON W, DONG QING, GONG XIANCHANG, KALDOR STEPHEN W, LIU YAN, PARASELLI BHEEMA R, SCORAH NICHOLAS, STAFFORD JEFFREY A, WALLACE MICHAEL B   +9 more
openaire   +7 more sources

The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway

Pharmacology & Therapeutics, 2002
Yasuharu Sasaki, Hiroyoshi Hidaka, Masaaki Suzuki   +2 more
exaly  

KINASE INHIBITORS

2013
HULL III CLARENCE E, MALONE THOMAS C
openaire   +4 more sources

Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors

Annals of Oncology, 2011
Shampa Das, M P Lolkema, P O Witteveen
exaly  

Kinases and kinase inhibitors

2020
Graham L. Patrick, Helen Turner
openaire   +1 more source

A comprehensive review of protein kinase inhibitors for cancer therapy

Expert Review of Anticancer Therapy, 2018
Daruka Mahadevan
exaly